News

Preeclampsia (high blood pressure during pregnancy) is the leading cause of stillbirths and newborn deaths in Australia. It also doubles a woman’s risk of heart disease and stroke later in life.

HRI's Professor Annemarie Hennessy talks to Channel 7 News about preeclampsia.

Scientists at the Heart Research Institute in Sydney have developed a simple, cheap and efficient way to collect nanoparticles that can be used in the treatment of cancer, cardiovascular disease and Alzheimer’s.

In Australia, cardiovascular disease continues to take the lives of 22 females every day – killing almost three times more women than breast cancer. Preeclampsia and gestational diabetes developed during pregnancy can significantly increase a woman’s risk of heart disease later in life, but these can be manageable complications if monitored.

Congratulations to Professor Annemarie Hennessy AM, recently named Distinguished Professor by Western Sydney University.

In March, HRI celebrated 30 years of groundbreaking research and new discoveries that have contributed to an improved understanding of cardiovascular disease.

The Federal Government has reaffirmed its commitment in the Budget to fully fund the Medical Research Future Fund (MRFF).

A new paper on how biomechanical thrombus growth is mediated has been published by the HRI team led by Prof Shaun Jackson and Dr Arnold (Lining) Ju in Nature Materials.

HRI researchers are a step closer to an exciting future where the human body does not reject lifesaving coronary bypass implants, a new study reveals.

Dr Steven Wise has been presented the prestigious National Health and Medical Research Council (NHMRC) Marshall and Warren Award.